Influence of Huazhuo Jiedu Formula on Nitric Oxide,Vasoactive Intestinal Peptide and Substance P of Rats with Reflux Esophagitis

ZHAO Yan; HUO Yongli; LI Bolin

doi:10.13288/j.11-2166/r.2015.07.018

您当前的位置：

首页 >

文章列表页 >

Influence of Huazhuo Jiedu Formula on Nitric Oxide,Vasoactive Intestinal Peptide and Substance P of Rats with Reflux Esophagitis

更新时间：2021-11-17

- Influence of Huazhuo Jiedu Formula on Nitric Oxide,Vasoactive Intestinal Peptide and Substance P of Rats with Reflux Esophagitis
- Journal of Traditional Chinese Medicine Vol. 56, Issue 7, Pages: 607-610(2015)
- 作者机构：
  
  1. 河北省中医院
  2. 河北医科大学
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2015.07.018
  CLC： R285.5
- Published：2015
- 稿件说明：
移动端阅览
[1]赵艳,霍永利,李博林.化浊解毒方对反流性食管炎大鼠一氧化氮、血管活性肠肽及P物质的影响[J].中医杂志,2015,56(07):607-610.

ZHAO Yan, HUO Yongli, LI Bolin. Influence of Huazhuo Jiedu Formula on Nitric Oxide,Vasoactive Intestinal Peptide and Substance P of Rats with Reflux Esophagitis[J]. Journal of Traditional Chinese Medicine2015, 56(7): 607-610.
[1]赵艳,霍永利,李博林.化浊解毒方对反流性食管炎大鼠一氧化氮、血管活性肠肽及P物质的影响[J].中医杂志,2015,56(07):607-610. DOI： 10.13288/j.11-2166/r.2015.07.018.

ZHAO Yan, HUO Yongli, LI Bolin. Influence of Huazhuo Jiedu Formula on Nitric Oxide,Vasoactive Intestinal Peptide and Substance P of Rats with Reflux Esophagitis[J]. Journal of Traditional Chinese Medicine2015, 56(7): 607-610. DOI： 10.13288/j.11-2166/r.2015.07.018.

摘要

目的探讨化浊解毒方治疗反流性食管炎的作用机制。方法将60只Wistar大鼠随机分为空白组、模型组、西药组、中药组

每组15只。除空白组外

其余3组采用"不全幽门结扎+贲门肌切开术"配合湿热环境加高脂高糖饮食的综合方法制备反流性食管炎大鼠模型。西药组给予奥美拉唑0.36 mg/100 g灌胃

中药组予化浊解毒方1.25 g/100 g灌胃

空白组、模型组予蒸馏水1 ml/100灌胃。治疗8周后观察大鼠食管黏膜的组织病理变化

检测食管组织一氧化氮（NO）浓度及食管黏膜血管活性肠肽（VIP）、P物质（SP）水平。结果中药组与西药组均能改善模型大鼠食管黏膜组织病理变化

与模型组比较差异有统计学意义（P<0.05）。中药组NO水平降低

SP表达升高

与模型组、西药组比较

差异有统计学意义（P<0.05）。中药组VIP表达降低

与模型组比较差异有统计学意义（P<0.05）

与西药组比较

差异无统计学意义（P>0.05）。结论化浊解毒方可能是通过升高SP表达

降低NO浓度及VIP表达

对反流性食管炎起到治疗作用。

Abstract

Objective To explore the mechanism of Huazhuo Jiedu Formula on reflux esophagitis. Methods Sixty normal Wistar rats were equally divided into blank control group

model group

western medicine treatment group and Chinese medicine treatment group. Three groups other than blank control group were all made reflux esophagitis models by a comprehensive method encompassing subtotal pylorus ligation

Heller myotomy

feeding damp-heat environment and high lipid and high sugar diet. After modeling

western medicine treatment group was intragastrically administrated by 0. 36 mg /100 g given omeprazole and traditional Chinese medicine treatment group was intragastrically administrated by 1. 25 g /100 g given Huazhuo Jiedu Formula

blank control group and model group were intragastrically administrated with distilled water. After 8 weeks

histopathological changes in esophagus tissues were observed.Meanwhile

the content of Nitric oxide（ NO） in esophageal tissue and the levels of vasoactive intestinal peptide（ VIP） and substance P（ SP） in esophagus tissues were tested. Results Pathological changes of esophageal mucosa were improved in both treatment groups

and the difference was statistically significant compared with model group（ P < 0. 05）. Decrease of NO concentration and increase of SP in Chinese medicine treatment group were significant difference（ P < 0. 05） compared with the model group and western medicine treatment group. Decrease of VIP in the Chinese medicine treatment group was significantly different（ P < 0. 05） compared with the model group

but was not significantly different（ P > 0. 05） compared with the western medicine group. Conclusion By means of elevating the levels of SP and reducing the levels of NO and VIP in esophagus tissues

Huazhuo Jiedu Formula can serve therapeutic effect on reflux esophagitis.

关键词

Keywords

references

查看原文

Views

215

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Experience in Treating Reflux Esophagitis with the Unblocking Method

Analysis of Animal Model Construction Methods of Different Subtypes of Gastroesophageal Reflux Disease Based on Literature

Effect of Electroacupuncture at Proximal and Distal Acupoints on Pain-inducing Substances， Macrophages and Related Inflammatory Factors in Myofascial Pain Syndrome Model Rats

Effect of Qingyu Hejiang Decoction（清郁和降汤）on LPS/TLR4/NFκB Pathway and Esophageal Mucosal Barrier in Reflux Esophagitis Model Rats

Effect of Liushen Capsules （六神胶囊） on Lipopolysaccharide-induced Inflammatory Response in RAW264.7 Macrophages： based on NF-κB Pathway

Related Author

TAN Cailin

YANG Yonghong²

WANG Xianbing²

CHEN Liwen²

MA Rongjie²

TANG Juan²

WANG Lu²

MAO Yihui

Related Institution

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

Pengzhou Hospital of Traditional Chinese Medicine

Deyang Hospital，Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

Beijing University of Chinese Medicine

Xiyuan Hospital，China Academy of Chinese Medical Sciences

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰